Masimo Corp Files Definitive Additional Materials

Ticker: MASI · Form: DEFA14A · Filed: Sep 13, 2024 · CIK: 937556

Masimo CORP DEFA14A Filing Summary
FieldDetail
CompanyMasimo CORP (MASI)
Form TypeDEFA14A
Filed DateSep 13, 2024
Risk Levellow
Pages12
Reading Time15 min
Key Dollar Amounts$2 billion, $6 billion, $8
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, sec-filing

Related Tickers: MASI

TL;DR

MASI filed more proxy docs, check for updates before voting.

AI Summary

Masimo Corporation filed definitive additional materials on September 13, 2024, related to its proxy statement. The filing is a definitive additional material, indicating it contains supplementary information for shareholders. No fee was required for this filing.

Why It Matters

This filing provides updated or supplementary information to shareholders regarding Masimo Corporation's proxy materials, which are crucial for voting on corporate matters.

Risk Assessment

Risk Level: low — This is a routine filing of additional proxy materials and does not inherently introduce new risks.

Key Players & Entities

FAQ

What type of filing is this for Masimo Corporation?

This is a DEFA14A filing, specifically 'Definitive Additional Materials'.

When was this filing made?

The filing was made on September 13, 2024.

Is there a filing fee associated with this document?

No fee was required for this filing.

What is the standard industrial classification for Masimo Corp?

The SIC code for Masimo Corp is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.

What is the business address of Masimo Corporation?

The business address is 52 Discovery, Irvine, CA 92618.

Filing Stats: 3,670 words · 15 min read · ~12 pages · Grade level 11.5 · Accepted 2024-09-13 06:06:28

Key Financial Figures

Filing Documents

Forward-Looking Statements

Forward-Looking Statements This communication includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo and the potential stockholder approval of the Board’s nominees. These forward-looking statements are based on current expectations about future events affecting Masimo and are cause its actual results to differ materially and adversely from those expressed in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding the Litigation, (ii) uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (iii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iv) factors discussed in the “Risk Factors” section of Masimo’s most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at www.sec.gov. Although Masimo believes that the expectations reflected in its forward-looking statements are reasonable, the Company does not know whether its expectations will prove correct. All forward-looking statements included in this communication are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing